PUCCI, MICHELA
PUCCI, MICHELA
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE (attivo dal 28/10/2011 al 31/12/2022)
A module of inflammatory cytokines defines resistance of colorectal cancer to EGFR inhibitors
2016 Gelfo, Valerio; Rodia, Maria Teresa; Pucci, Michela; Dall'Ora, Massimiliano; Santi, Spartaco; Solmi, Rossella; Roth, Lee; Lindzen, Moshit; Bonafè, Massimiliano; Bertotti, Andrea; Caramelli, Elisabetta; Lollini, Pier-Luigi; Trusolino, Livio; Yarden, Yosef; D'Uva, Gabriele; Lauriola, Mattia
Glycobiology of the epithelial to mesenchymal transition
2021 Pucci M.; Malagolini N.; Dall'Olio F.
Glycosylation as a Main Regulator of Growth and Death Factor Receptors Signaling
2018 Ferreira, Inês Gomes; Pucci, Michela; Venturi, Giulia; Malagolini, Nadia; Chiricolo, Mariella; Dall’Olio, Fabio
Glycosyltransferase b4galnt2 as a predictor of good prognosis in colon cancer: Lessons from databases
2021 Pucci M.; Malagolini N.; Dall'olio F.
Glycosyltransferases in Cancer: Prognostic Biomarkers of Survival in Patient Cohorts and Impact on Malignancy in Experimental Models
2022 Pucci M.; Duca M.; Malagolini N.; Dall'Olio F.
High Expression of the Sda Synthase B4GALNT2 Associates with Good Prognosis and Attenuates Stemness in Colon Cancer
2020 Pucci M.; Gomes Ferreira I.; Orlandani M.; Malagolini N.; Ferracin M.; Dall'Olio F.
Impact of sialyltransferase ST6GAL1 overexpression on different colon cancer cell types
2019 Venturi G.; Gomes Ferreira I.; Pucci M.; Ferracin M.; Malagolini N.; Chiricolo M.; Dall'Olio F.
Mechanisms of acquired resistance to cetuximab: role of interleukin 1
2016 Valerio Gelfo, Michela Pucci, Moshit Lindzen, Maria Teresa Rodia, Rossella Solmi, Massimiliano Bonafè, Elisabetta Caramelli, Yosef Yarden, Mattia Lauriola.
Mechanisms of acquired resistance to cetuximab: role of interleukin-1
2017 Valerio Gelfo, Michela Pucci, Moshit Lindzen, Maria Teresa Rodia, Rossella Solmi, Massimiliano Bonafè, Elisabetta Caramelli, Yosef Yarden, Mattia Lauriola
Mechanisms of acquired resistance to cetuximab: role of interleukin-1
2017 Valerio Gelfo, Michela Pucci, Moshit Lindzen, Martina Mazzeschi, Massimiliano Bonafè, Rossella Solmi, Gabriele D’Uva, Yosef Yarden, Mattia Lauriola
Resistance to EGFR Targeting Treatments in Colorectal Cancer
2019 Pucci, Michela; Lauriola, Mattia
The cancer-associated antigens sialyl lewisa/x and sda: Two opposite faces of terminal glycosylation
2021 Dall'olio F.; Pucci M.; Malagolini N.
The Sda synthase B4GALNT2 reduces malignancy and stemness in colon cancer cell lines independently of sialyl lewis X inhibition
2020 Pucci M.; Gomes Ferreira I.; Malagolini N.; Ferracin M.; Dall'olio F.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| A module of inflammatory cytokines defines resistance of colorectal cancer to EGFR inhibitors | Gelfo, Valerio; Rodia, Maria Teresa; Pucci, Michela; Dall'Ora, Massimiliano; Santi, Spartaco; Sol...mi, Rossella; Roth, Lee; Lindzen, Moshit; Bonafè, Massimiliano; Bertotti, Andrea; Caramelli, Elisabetta; Lollini, Pier-Luigi; Trusolino, Livio; Yarden, Yosef; D'Uva, Gabriele; Lauriola, Mattia | 2016-01-01 | ONCOTARGET | - | 1.01 Articolo in rivista | 2016 - Gelfo Oncotarget 2016.pdf |
| Glycobiology of the epithelial to mesenchymal transition | Pucci M.; Malagolini N.; Dall'Olio F. | 2021-01-01 | BIOMEDICINES | - | 1.01 Articolo in rivista | Review EMT.pdf |
| Glycosylation as a Main Regulator of Growth and Death Factor Receptors Signaling | Ferreira, Inês Gomes; Pucci, Michela; Venturi, Giulia; Malagolini, Nadia; Chiricolo, Mariella; Da...ll’Olio, Fabio | 2018-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | ijms-19-00580.pdf |
| Glycosyltransferase b4galnt2 as a predictor of good prognosis in colon cancer: Lessons from databases | Pucci M.; Malagolini N.; Dall'olio F. | 2021-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | Pucci et al databases.pdf; Fig. S1.pptx; Fig. S2.pptx; Fig. S3.pptx; Table S1.xlsx |
| Glycosyltransferases in Cancer: Prognostic Biomarkers of Survival in Patient Cohorts and Impact on Malignancy in Experimental Models | Pucci M.; Duca M.; Malagolini N.; Dall'Olio F. | 2022-01-01 | CANCERS | - | 1.01 Articolo in rivista | Glycosyltransferases survival.pdf; cancers-14-02128-s001.zip |
| High Expression of the Sda Synthase B4GALNT2 Associates with Good Prognosis and Attenuates Stemness in Colon Cancer | Pucci M.; Gomes Ferreira I.; Orlandani M.; Malagolini N.; Ferracin M.; Dall'Olio F. | 2020-01-01 | CELLS | - | 1.01 Articolo in rivista | Pucci et al Cells 2020.pdf; Table S1 pathways B4.xlsx; Table S2 modulated by 3D 4.xlsx; Table S3 pathways 3D.xlsx; Table S4 modulated 3D only in B4.xlsx |
| Impact of sialyltransferase ST6GAL1 overexpression on different colon cancer cell types | Venturi G.; Gomes Ferreira I.; Pucci M.; Ferracin M.; Malagolini N.; Chiricolo M.; Dall'Olio F. | 2019-01-01 | GLYCOBIOLOGY | - | 1.01 Articolo in rivista | submitted rev bis.pdf |
| Mechanisms of acquired resistance to cetuximab: role of interleukin 1 | Valerio Gelfo, Michela Pucci, Moshit Lindzen, Maria Teresa Rodia, Rossella Solmi, Massimiliano Bo...nafè, Elisabetta Caramelli, Yosef Yarden, Mattia Lauriola. | 2016-01-01 | - | - | 4.01 Contributo in Atti di convegno | - |
| Mechanisms of acquired resistance to cetuximab: role of interleukin-1 | Valerio Gelfo, Michela Pucci, Moshit Lindzen, Maria Teresa Rodia, Rossella Solmi, Massimiliano Bo...nafè, Elisabetta Caramelli, Yosef Yarden, Mattia Lauriola | 2017-01-01 | - | - | 4.01 Contributo in Atti di convegno | - |
| Mechanisms of acquired resistance to cetuximab: role of interleukin-1 |
Valerio Gelfo, Michela Pucci, Moshit Lindzen, Martina Mazzeschi, Massimiliano Bonafè, Rossella S...olmi, Gabriele D’Uva, Yosef Yarden, Mattia Lauriola |
2017-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
| Resistance to EGFR Targeting Treatments in Colorectal Cancer | Pucci, Michela; Lauriola, Mattia | 2019-01-01 | - | Franco Dammacco and Franco Silvestris | 2.01 Capitolo / saggio in libro | - |
| The cancer-associated antigens sialyl lewisa/x and sda: Two opposite faces of terminal glycosylation | Dall'olio F.; Pucci M.; Malagolini N. | 2021-01-01 | CANCERS | - | 1.01 Articolo in rivista | Review Sda sLex 2021.pdf |
| The Sda synthase B4GALNT2 reduces malignancy and stemness in colon cancer cell lines independently of sialyl lewis X inhibition | Pucci M.; Gomes Ferreira I.; Malagolini N.; Ferracin M.; Dall'olio F. | 2020-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | Pucci IJMS 2020.pdf; Fig. S1.pptx; Table S1.docx; Table S2.docx; Table S3.docx |